Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 3

Results For "Head"

2417 News Found

Biocon appoints Karthik SM as Head HR for India, Malaysia and Emerging Markets
People | April 15, 2026

Biocon appoints Karthik SM as Head HR for India, Malaysia and Emerging Markets

In his new role, Karthik will lead human capital strategy and HR operations across these regions


Dabur reports steady domestic growth amid global headwinds in Q4 FY26
News | April 08, 2026

Dabur reports steady domestic growth amid global headwinds in Q4 FY26

The India FMCG business showed a sequential recovery and is expected to post high-single digit growth


Dr Reddy’s elevates Saran PS as Head of Launch Excellence and Program Management
People | April 06, 2026

Dr Reddy’s elevates Saran PS as Head of Launch Excellence and Program Management

In his new role, Saran will spearhead the end-to-end launch framework for innovation-led portfolio


Sanofi appoints Dr Parikshit Chaudhari as Head of Market Access & Pricing Strategy
People | April 06, 2026

Sanofi appoints Dr Parikshit Chaudhari as Head of Market Access & Pricing Strategy

He brings extensive cross-functional expertise built through leadership roles


Sygnature Discovery appoints Susanne Back as Head of In Vivo Pharmacology
People | April 01, 2026

Sygnature Discovery appoints Susanne Back as Head of In Vivo Pharmacology

She brings 20 years of in vivo pharmacology experience across academia and industry, including senior scientific and leadership roles at Orion Pharma and Charles River


India tackles rare diseases head-on at landmark summit in New Delhi
News | March 12, 2026

India tackles rare diseases head-on at landmark summit in New Delhi

Industry leaders highlighted the pharmaceutical sector’s role in advancing research, innovation, early screening, and multi-stakeholder collaboration


Sumitomo Pharma bags world-first go-ahead for iPS cell therapy to treat Parkinson’s disease
News | March 10, 2026

Sumitomo Pharma bags world-first go-ahead for iPS cell therapy to treat Parkinson’s disease

The conditional, time-limited approval comes through a joint effort with RACTHERA, a joint venture in which Sumitomo Chemical holds a 66.6% stake and Sumitomo Pharma holds 33.4%


Merck delivers resilient 2025 performance despite global headwinds
News | March 06, 2026

Merck delivers resilient 2025 performance despite global headwinds

Strong performances in its Life Science, Healthcare and Electronics divisions — particularly Process Solutions, Cardiovascular treatments and Semiconductor Materials — powered the company’s results


Roche appoints Mark Dawson as new Head of Pharma Research and Early Development
People | February 17, 2026

Roche appoints Mark Dawson as new Head of Pharma Research and Early Development

Dawson joins Roche from the Peter MacCallum Cancer Centre, where he serves as Associate Director of Research


Wanbury reports explosive Q3 profit surge, signals strong growth ahead
News | February 09, 2026

Wanbury reports explosive Q3 profit surge, signals strong growth ahead

Call it one of the most striking turnarounds in the Indian pharma sector this fiscal year